FKBP14 is a 22-kilodalton protein that contains several important structural motifs:
FKBP14 is primarily located in the endoplasmic reticulum and is involved in the folding and assembly of newly synthesized proteins. It acts as a chaperone, assisting in the proper folding of proteins that contain proline residues. This function is essential for maintaining cellular homeostasis and preventing the accumulation of misfolded proteins, which can lead to various diseases.
Mutations in the FKBP14 gene have been associated with a rare genetic disorder known as FKBP14-related Ehlers-Danlos syndrome (EDS). This condition is characterized by joint hypermobility, skin hyperextensibility, and other connective tissue abnormalities. The discovery of FKBP14’s role in this syndrome has provided valuable insights into the molecular mechanisms underlying connective tissue disorders .
FKBP14, like other members of the FKBP family, has been the subject of extensive research due to its involvement in various cellular processes and its potential as a therapeutic target. The ability of FKBP14 to bind immunosuppressive drugs such as FK506 and rapamycin has made it a valuable tool in studying immune regulation and developing new treatments for autoimmune diseases and transplant rejection .